copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
International Classification of Diseases for Oncology, 3rd Edition (ICD . . . Purpose Definition Used principally in tumour or cancer registries for coding the site (topography) and the histology (morphology) of neoplasms, usually obtained from a pathology report Classification structure ICD-O is a multi-axial classification of the site, morphology, behaviour, and grading of neoplasms
Cancer - World Health Organization (WHO) Cancer is more likely to respond to effective treatment when identified early, resulting in a greater probability of surviving as well as less morbidity and less expensive treatment There are two distinct strategies that promote early detection: Early diagnosis identifies symptomatic cancer cases at the earliest possible stage Screening aims to identify individuals with abnormalities
Childhood cancer - World Health Organization (WHO) Cancer is a leading cause of death for children and adolescents worldwide In high-income countries more than 80% of children with cancer are cured, but in many lower-middle-income countries only 30% are cured
WHO target product profiles WHO target product profiles A target product profile (TPP) outlines the desired ‘profile’ or characteristics of a target product that is aimed at a particular disease or diseases TPPs state intended use, target populations and other desired attributes of products, including safety and efficacy-related characteristics Such profiles can guide product research and development (R D): In
Palliative care - World Health Organization (WHO) Palliative care is a crucial part of integrated, people-centred health services (IPCHS) Nothing is more people-centred than relieving their suffering, be it physical, psychological, social, or spiritual Thus, whether the cause of suffering is cancer or major organ failure, drug-resistant tuberculosis or severe burns, end-stage chronic illness or acute trauma, extreme birth prematurity or
Ionizing radiation and health effects WHO fact sheet on ionizing radiation, health effects and protective measures: includes key facts, definition, sources, type of exposure, health effects, nuclear emergencies, WHO response
Biosimilars: expanding access to essential biologic therapies Biologic medicines have transformed treatment for numerous chronic and life-threatening conditions such as cancer, auto-immune diseases, and diabetes These therapies can offer significant benefits in efficacy, safety, and convenience, compared to conventional medicines However, their high costs have limited accessibility for many patients globally Biosimilar versions of biologic medicines
Annex 1 - World Health Organization (WHO) These guidelines are consistent with the requirements of the WHO guidelines for good manufacturing practices (1) and with the requirements of the International Standard ISO IEC 17025:2005 (2), and provide detailed guidance for laboratories performing quality control of medicines The guidance specifi c to microbiology laboratories can be found in the draft working document WHO guideline on